Skip to content

Category Archives: BioThrax


  1. Emergent’s Fuad El-Hibri, an entrepreneur at heart April 2, 2012

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Financial Performance, Food and Drug Administration, Fuad El-Hibri, Healthcare, Trubion Pharmaceuticals, Vaccine, Yale University.

    No comments
  2. Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government October 14, 2011

    Posted in BioDefense, BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, U.S. Food and Drug Administration.

    No comments
  3. Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax July 7, 2011

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad Elhibri, Healthcare, U.S. Food and Drug Administration.

    No comments
  4. Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule June 7, 2011

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri.

    No comments
  5. Emergent BioSolutions Reports Financial Results for First Quarter 2011 May 12, 2011

    Posted in BioDefense, BioThrax, Business, Chief executive officer, Chief financial officer, Revenue.

    No comments
  6. Emergent BioSolutions Reports Financial Results for Full Year 2010 April 13, 2011

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Financial Results, Fuad El-Hibri, Trubion Pharmaceuticals.

    No comments
  7. Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine January 4, 2011

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.

    No comments
  8. Fuad El-Hibri and the International Biomedical Research Alliance November 13, 2010

    Posted in BioThrax, Chief executive officer, El-Hibri, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States.

    No comments
  9. Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 October 23, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NYSE, Vaccine.

    No comments
  10. Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine September 20, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.

    No comments
  11. Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine September 10, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Vaccine.

    No comments
  12. Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars August 30, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad Elhibri, Scholars Program.

    No comments
  13. Emergent BioSolutions to Acquire Trubion Pharmaceuticals August 18, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Shareholders, Trubion Pharmaceuticals.

    No comments
  14. Emergent Revises Upward 2010 Financial Forecast August 3, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, United States, Vaccine.

    No comments
  15. Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility July 27, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Vaccine.

    No comments
  16. Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax July 15, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.

    No comments
  17. Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians July 13, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri, United States Department of Defense, United States Department of Health and Human Services.

    No comments
  18. Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments July 7, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Washington.

    No comments
  19. Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader March 15, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Ernst & Young Entrepreneur of the Year, Fuad El-Hibri.

    No comments
  20. Bad News Clouds Two Bio Defense Stocks December 11, 2009

    Posted in BioThrax, Chief executive officer, El-Hibri Fuad, Emergent BioSystems, Ernst & Young Entrepreneur of the Year, Fuad El-Hibri, Medical, Uncategorized, biotechnology, technology.

    No comments
  21. Fuad El-Hibri and BioThrax June 16, 2009

    Posted in BioThrax, El-Hibri Fuad, Fuad El-Hibri, Fuad Elhibri.

    No comments
    22. DeliciousDiggFacebook
    RSS FeedStumbleUponTwitter